Detalhe da pesquisa
1.
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine.
J Infect Dis;
227(2): 251-255, 2023 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36108092
2.
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.
Lancet Microbe;
4(9): e670-e682, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37549680